In order to understand the in vivo relevance of SMPDL3b in the context of diabetic complications that are linked to impaired insulin signaling such as DKD, we generated podocyte-specific Smpdl3b-deficient mice. Here, SMPDL3B is linked to diabetic kidney disease.